Table 1.
Enzyme cleavage activities of mutated substrate peptides
| Substrate | Sequencea | Apparent kcat/Km (mM−1 min−1)b | (kcat/Km)rel |
|---|---|---|---|
| S12 | SAVLQ ↓ SGF-CONH2 | 2.13 ± 0.20 | 1.00 |
| P5L | LAVLQ ↓ SGF-CONH2 | 8.32 ± 0.25 | 3.90 |
| P5T | TAVLQ ↓ SGF-CONH2 | 7.80 ± 0.24 | 3.66 |
| P5V | VAVLQ ↓ SGF-CONH2 | 7.66 ± 0.30 | 3.59 |
| P5A | AAVLQ ↓ SGF-CONH2 | 7.10 ± 0.24 | 3.33 |
| P4L | SLVLQ ↓ SGF-CONH2 | 0.33 ± 0.04 | 0.15 |
| P4T | STVLQ ↓ SGF-CONH2 | 3.14 ± 0.12 | 1.47 |
| P4V | SVVLQ ↓ SGF-CONH2 | 5.21 ± 1.27 | 2.44 |
| P3L | SALLQ ↓ SGF-CONH2 | 1.85 ± 0.06 | 0.87 |
| P3T | SATLQ ↓ SGF-CONH2 | 2.53 ± 0.54 | 1.19 |
| P3A | SAALQ ↓ SGF-CONH2 | 0.40 ± 0.03 | 0.19 |
| P3K | SAKLQ ↓ SGF-CONH2 | 5.72 ± 0.45 | 2.68 |
| P1′A | SAVLQ ↓ AGF-CONH2 | 4.36 ± 0.19 | 2.04 |
| P1′G | SAVLQ ↓ GGF-CONH2 | 1.76 ± 0.09 | 0.83 |
| P1′L | SAVLQ ↓ LGF-CONH2 | NDc | |
| S12 | SAVLQ ↓ SGF-CONH2 | 12.68 ± 0.60* | 1.000 |
| P2M | SAVMQ ↓ SGF-CONH2 | 2.54 ± 0.07* | 0.208 |
| P2F | SAVFQ ↓ SGF-CONH2 | 0.58 ± 0.10* | 0.046 |
| P2I | SAVIQ ↓ SGF-CONH2 | 0.080 ± 0.011* | 0.0063 |
| P2V | SAVVQ ↓ SGF-CONH2 | 0.070 ± 0.009* | 0.0056 |
| P2A | SAVAQ ↓ SGF-CONH2 | 0.058 ± 0.008* | 0.0046 |
| P2R | SAVRQ ↓ SGF-CONH2 | NDc,* | |
| P1N | SAVLN ↓ SGF-CONH2 | NDc,* | |
| P1E | SAVLE ↓ SGF-CONH2 | NDc,* | |
| P1K | SAVLK ↓ SGF-CONH2 | NDc,* | |
| S21 | TVVLQ ↓ SGF-CONH2 | 8.48 ± 1.32 | 3.98 |
| S22 | TVTLQ ↓ SGF-CONH2 | 5.58 ± 0.21 | 2.62 |
| S23 | VVTLQ ↓ SGF-CONH2 | 5.18 ± 0.74 | 2.43 |
| S24 | TVKLQ ↓ AGF-CONH2 | 9.18 ± 0.25 | 4.31 |
Mutated residues are underlined. Cleavage sites are indicated by ↓.
The concentration of SARS 3C-like proteinase is 5.41 μM for substrates without any label and that for substrates labeled with asterisk is 27.05 μM.
Not detectable in HPLC-based peptide cleavage assay.